Peroxisome proliferator-activated receptors for hypertension

doi:10.4330/wjc.v6.i8.744

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 8

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9788)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

551

WORD

283

HTML

6307

Figures (1-4)

274

Sum=7415

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1172

Download

1201

Sum=2373

Aug 26, 2014 (publication date) through Jul 29, 2024

Times Cited of This Article

Times Cited (56)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Cardiol. Aug 26, 2014; 6(8): 744-754
Published online Aug 26, 2014. doi: 10.4330/wjc.v6.i8.744

Full Size Figure Download Figure

Figure 4 Possible effects of Peroxisome proliferator-activated receptor γ agonists. PPAR: Peroxisome proliferator-activated receptor; AT1R: Ang-II type 1 receptor; RAAS: Renin-angiotensin-aldosterone system; TX: Thromboxane; TXS: TX synthase; TXR: TX receptor; VSMC: Vascular smooth muscle cells; DM: Diabetes mellitus. Table adapted from reference[71].

Citation: Usuda D, Kanda T. Peroxisome proliferator-activated receptors for hypertension. World J Cardiol 2014; 6(8): 744-754
URL: https://www.wjgnet.com/1949-8462/full/v6/i8/744.htm
DOI: https://dx.doi.org/10.4330/wjc.v6.i8.744